We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$51.2M
Cap. Flow
-$43M
Cap. Flow %
-4.01%
Top 10 Hldgs %
8.18%
Holding
1,747
New
747
Increased
219
Reduced
207
Closed
574

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.1M
2
AAPL icon
Apple
AAPL
+$8.41M
3
MSI icon
Motorola Solutions
MSI
+$7.68M
4
JD icon
JD.com
JD
+$7.3M
5
ITW icon
Illinois Tool Works
ITW
+$6.58M

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$11.4M
2
KVUE icon
Kenvue
KVUE
+$8.1M
3
RTX icon
RTX Corp
RTX
+$7.61M
4
CSCO icon
Cisco
CSCO
+$6.72M
5
ADBE icon
Adobe
ADBE
+$6.58M

Sector Composition

Rank Sector Weight
1 Technology 16.62%
2 Financials 15.83%
3 Consumer Discretionary 13.61%
4 Healthcare 10.98%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWY icon
351
iShares Russell Top 200 Growth ETF
IWY
$15.7B
$901K 0.08%
+5,144
New +$844K
APLS
352
DELISTED
Apellis Pharmaceuticals
APLS
$898K 0.08%
+15,008
New +$761K
AXSM icon
353
Axsome Therapeutics
AXSM
$12.3B
$898K 0.08%
+11,285
New +$754K
NTES icon
354
NetEase
NTES
$79.2B
$892K 0.08%
9,570
+3,529
+58% +$375K
BROS icon
355
Dutch Bros
BROS
$9.01B
$891K 0.08%
+28,135
New +$766K
SPHQ icon
356
Invesco S&P 500 Quality ETF
SPHQ
$19.5B
$888K 0.08%
16,427
+7,432
+83% +$382K
RPD icon
357
Rapid7
RPD
$643M
$888K 0.08%
15,554
+6,415
+70% +$335K
MED icon
358
Medifast
MED
$110M
$886K 0.08%
+13,188
New +$919K
FBP icon
359
First Bancorp
FBP
$4.39B
$882K 0.08%
+53,612
New +$792K
BCE icon
360
BCE
BCE
$19.8B
$882K 0.08%
22,386
-39,339
-64% -$1.52M
GL icon
361
Globe Life
GL
$13.5B
$877K 0.08%
+7,201
New +$847K
YOU icon
362
Clear Secure
YOU
$5.36B
$873K 0.08%
+42,293
New +$822K
FCFS icon
363
FirstCash
FCFS
$9.06B
$872K 0.08%
+8,048
New +$871K
BN icon
364
Brookfield
BN
$103B
$872K 0.08%
+32,591
New +$740K
SEB icon
365
Seaboard Corp
SEB
$4.42B
$871K 0.08%
+244
New +$868K
FIVN icon
366
FIVE9
FIVN
$1.96B
$871K 0.08%
11,070
-16,819
-60% -$1.17M
DVN icon
367
Devon Energy
DVN
$49.8B
$871K 0.08%
19,220
+6,751
+54% +$309K
EEFT icon
368
Euronet Worldwide
EEFT
$3.01B
$870K 0.08%
8,576
-10,232
-54% -$873K
J icon
369
Jacobs Solutions
J
$16B
$867K 0.08%
+8,075
New +$879K
ABG icon
370
Asbury Automotive
ABG
$4.22B
$866K 0.08%
+3,851
New +$814K
ZS icon
371
Zscaler
ZS
$23.8B
$862K 0.08%
+3,889
New +$720K
AAXJ icon
372
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.66B
$859K 0.08%
+12,911
New +$830K
SIMO icon
373
Silicon Motion
SIMO
$8.29B
$858K 0.08%
14,007
+1,788
+15% +$102K
KT icon
374
KT
KT
$8.92B
$854K 0.08%
+63,538
New +$813K
IART icon
375
Integra LifeSciences
IART
$1.52B
$852K 0.08%
+19,572
New +$770K

Similar funds

Y-Intercept (HK)'s Q4 2023 Portfolio in Review

As of Q4 2023, Y-Intercept (HK) held 1,747 positions worth $1.07B, up 5% from $1.02B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Y-Intercept (HK) withdrew a net $43M in Q4 2023, closing 574 positions and reducing 207 holdings. Its most notable exit was Blackstone, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Y-Intercept (HK) opened a new position in Merck worth $12.7M.

  • Y-Intercept (HK)'s largest Q4 2023 buy was Merck: 116,714 shares worth $12.7M.
  • Y-Intercept (HK) added most to Apple in Q4 2023, an estimated $8.41M increase.
  • Y-Intercept (HK)'s biggest Q4 2023 reduction was Kenvue, cutting an estimated $8.1M.
  • Y-Intercept (HK) fully exited Blackstone in Q4 2023, selling an estimated $11.4M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $1.07B portfolio in Q4 2023.
  • Y-Intercept (HK) opened 747 new positions and closed 574 in Q4 2023.
  • Y-Intercept (HK)'s portfolio value rose 5% quarter-over-quarter to $1.07B.

Based on Y-Intercept (HK)'s 13F filing for Q4 2023, filed 13 Feb 2024.